biomedical imaging News
-
The NIH Honors Dr. Quyen T. Nguyen for Her Contributions to Research and Science
Alume Biosciences announces today that the National Institute of Health (NIH) has honored Dr. Quyen T. Nguyen, MD/PhD, founder of Alume Biosciences and professor of at UC San Diego, in its new website series, Women In Science and Engineering (WISE). Dr. Nguyen is an NIH National Institute of Biomedical Imaging and Bioengineering (NIBIB) grantee. The NIH is committed to creating a supportive ...
-
Aidoc launches the first ai-based automated notification solution for high-risk pulmonary embolism patients
Aidoc, the leading provider of enterprise AI solutions, announced today the launch of an industry first: an AI-based automated activation solution that facilitates rapid risk assessment and care coordination for high-risk pulmonary embolism (PE) patients. Aidoc’s PE Care Coordination includes Aidoc’s FDA-cleared solution for triage and notification of PE. The solution is ...
By Aidoc
-
Prof. Dr. med. Michael Schmitt, MHBA has joined Ardigen`s Scientific Board to support the development of AI platforms for cell therapy discovery
Ardigen, one of the world-leading companies that utilizes artificial intelligence (AI) algorithms for drug discovery, is proud to announce that Prof. Dr. Michael Schmitt, MHBA, has joined the company’s Scientific Advisory Board. His knowledge and experience will support work on artificial intelligence-based platforms, dedicated to accelerating and optimizing the discovery of novel cell ...
By Ardigen
-
PERKINELMER HOSTS FT-IR BIOMEDICAL IMAGING MEDIA ROUNDTABLE
Event Brings Together Experts from Rutgers University, Hunter College and Brookhaven National Laboratory to Discuss Emerging Application of FT-IR Technology in Disease Research ( NEWARK , N.J. ) – PerkinElmer Inc. (NYSE: PKI ), a leading provider of drug discovery, life science research, and analytical solutions, today brought together leading researchers from academia and industry to ...
-
CD Bioparticles Launches NIR-Quantum Dots for Biomedical Imaging
With years of experience in the pharmaceutical and life science sector, CD Bioparticles launched a range of near-infra-red (NIR) quantum dots that exhibit excellent optical properties and biocompatibility for biomedical imaging. Currently, CD Bioparticles has successfully synthesized a variety of NIR quantum dots, including PbS/CdS, PbS, PbSe, Ag2S, CuInS/ZnS, and CdTe/CdSe/ZnS. Quantum points ...
-
Mariola Fotin-Mleczek, PhD, has joined Ardigen’s Scientific Board to support the drug discovery process for cancer immunology therapies
Ardigen, one of the world’s leading companies that utilizes artificial intelligence (AI) algorithms for drug discovery, is proud to announce that Mariola Fotin-Mleczek, PhD, has joined Ardigen’s Scientific Board. Her knowledge and experience will support a deeper understanding of active cancer immunotherapies in the drug discovery process provided by scientific innovation. Mariola ...
By Ardigen
-
Cancer Targeted Technology Receives $2 Million Small Business Innovation (SBIR) Grant to Advance its PET Imaging Diagnostic to Clinical Trials in Prostate Cancer
Cancer Targeted Technology (CTT), a privately-held Seattle-based biotechnology firm focusing on cancer diagnostics and therapeutics, today announced that the NIH awarded a 2-year, $2M SBIR grant to CTT to develop a new agent that will help diagnose and monitor metastatic prostate cancer. CTT1057, a positron emission tomography (PET) imaging agent, discovered by Dr. Cliff Berkman, Professor of ...
-
Subtle Medical Awarded Federal SBIR Grant for Safer Fluoroscopy Exams
Subtle Medical was awarded an NIH SBIR grant to develop an innovative artificial intelligence (AI)-powered software, SubtleIR™, which uses deep learning (DL) to reduce radiation dosage needed during fluoroscopy exams. The development of the new software is aligned with the company’s mission to accelerate access to faster, safer, and smarter medical imaging. Subtle continues to ...
-
Mammoth Biosciences Receives FDA Emergency Use Authorization for First CRISPR-based High-Throughput COVID-19 Test
Mammoth Biosciences, Inc., today announced that the U.S. Food and Drug Administration (FDA) has granted Emergency Use Authorization (EUA) for its DETECTR BOOST® SARS-CoV-2 Reagent Kit, a first of its kind high-throughput solution that combines the power of CRISPR with laboratory automation for SARS-CoV-2 testing. The DETECTR BOOST platform is a turnkey, CRISPR-based molecular diagnostic ...
-
Agnieszka Blum, MD, PhD has been promoted to the Management Board of Ardigen to strengthen drug discovery expertise
Ardigen, a global leader in artificial intelligence for drug discovery, is proud to announce that Agnieszka Blum, MD, PhD has joined the company’s Board of Management. She brings with her extensive knowledge and experience in the field of Immuno-Oncology and drug discovery, which is strategic for Ardigen’s development. Agnieszka Blum, MD, PhD will continue her mission as the General ...
By Ardigen
-
New Rapid Molecular COVID-19 Test from Anavasi Diagnostics Awarded $14.9 Million by NIH to Accelerate Test Availability
Anavasi Diagnostics, a medical technology company focused on the development of novel molecular diagnostic testing using a proprietary patent-pending reverse transcriptase methodology, today announced it has been awarded $14.9 million from the National Institutes of Health (NIH) Rapid Acceleration of Diagnostics (RADx) initiative. The funding will accelerate the launch and broad market ...
-
NIH Awards ~$144 Million in Research on Environmental Influences on Child Health and Development
The National Institutes of Health has awarded nearly $144 million in new grants to develop new tools and measures that can be used to investigate more effectively environmental exposures from the womb through later years in a child’s life. These projects will enhance the next phase of research on the effects of environmental exposures on child health and development. “Technology ...
-
Profusa, Inc. Receives CE Mark to Market the Lumee Oxygen Platform™ for Continuous, Real-time Monitoring of Tissue Oxygen
Profusa, Inc., a developer of tissue-integrated biosensors for continuous monitoring of body chemistry, today announced that it received the CE Mark to market its Lumee Oxygen Platform™ for continuous, real-time monitoring of tissue oxygen. The company will initially market the system for monitoring tissue oxygen in the treatment of peripheral artery disease (PAD). With an ...
-
GE Researches dedicated MRI Brain Scanner Technology
Driving new technologies that will help expand the availability of MRI scanners beyond the hospital to smaller clinic settings, GE Global Research, the technology development arm for the General Electric Company (NYSE: GE), and Mayo Clinic, have received a five-year, $5.7 million grant from the National Institute of Biomedical Imaging and Bioengineering (NIBIB), and the National Institute of ...
By GE Power
-
Prof. Krestin Joins Fluidda’S Board of Directors
INTRODUCTION Gabriel Krestin received his MD from the University of Cologne, Germany where he also specialized in radiology, in 1981 and his PhD (Habilitation) in 1989. From 1990–1997, he worked at the University Hospital in Zürich/CH, including a period as acting chairman of the Department of Radiology. In 1997 he moved to Erasmus MC in Rotterdam, Netherlands where he was the ...
By Fluidda
-
Collaboration in Innovation and Commercialization of Key Technologies Across the Pacific
Industrial Technology Research Institute (ITRI), Taiwan's largest and one of the world's leading high-tech research and development institutions, announces its 2012 ITRI Forum and Career Fair, Collaboration in Innovation and Commercialization Across the Pacific. The event, scheduled on June 25, 2012, at the Crowne Plaza Hotel in Milpitas, Calif., will draw Silicon Valley technology leaders, ...
-
OPKO Health Acquires ModeX Therapeutics, Gains Proprietary Immunotherapy Technology with a Focus on Oncology and Infectious Diseases
Dr. Elias Zerhouni, ModeX Chairman, former President of Global R&D at Sanofi and former NIH Director, named President and Vice Chairman of OPKO Dr. Gary Nabel, ModeX President and CEO, former Chief Scientific Officer at Sanofi and founder of NIH’s Vaccine Research Center, joins OPKO as Chief Innovation Officer and a member of OPKO’s Board of Directors Alexis Borisy, ModeX Lead ...
-
Halifax Biomedical Inc. announces collaboration with GE Healthcare
Halifax Biomedical Inc (HBI), a leading provider of orthopedic diagnostics using ultra high precision stereo x-ray imaging technology, and GE Healthcare have entered into a collaboration to provide HBI’s stereo x-ray based orthopedic clinical measurements to GE’s existing customers. Under a joint development agreement, HBI and GE have created a Halifax imaging upgrade for existing GE ...
-
MultiModal Molecular Imaging Institute at Maastricht University Joins Waters Centers of Innovation Program
At a ceremony and symposium at Maastricht University, The Netherlands, Waters Corporation (NYSE:WAT) officially welcomed the Maastricht MultiModal Molecular Imaging Institute M4I into the Waters Centers of Innovation (COI) Program. Under the direction of Professor Ron Heeren, the institute conducts research into applications for mass spectrometry in three main areas: oncology, neurology and ...
Need help finding the right suppliers? Try XPRT Sourcing. Let the XPRTs do the work for you